☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Aeglea Bio Therapeutics
Aeglea Bio Therapeutics Reports P-I/II Clinical Trial Results of Pegtarviliase for the Treatment of Classical Homocystinuria
April 13, 2023
Load more...
Back to Home
Modal title
×
Modal body text goes here.